Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-21-024855
Filing Date
2021-07-19
Accepted
2021-07-19 21:30:35
Documents
1
Period of Report
2021-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 6418
  Complete submission text file 0001140361-21-024855.txt   8138
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Issuer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BROOKLYN IMMUNOTHERAPEUTICS, INC. 140 58TH STREET, BUILDING A, SUITE 2100 BROOKLYN NY 11220
Business Address
Sial Jay (Reporting) CIK: 0001873057 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11460 | Film No.: 211099284